Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02425228 · ClinicalTrials.gov registry record
Prospective Assessment of Image Registration for the Diagnosis of Prostate Cancer
A clinical trial, sponsored by Jonsson Comprehensive Cancer Center.
- Completed
- Registry status
- 300
- Enrollment target
NCT02425228 is a clinical trial that has completed, run by Jonsson Comprehensive Cancer Center. The registered enrollment target is 300 participants.
The verdict
NCT02425228 has completed, sponsored by Jonsson Comprehensive Cancer Center.
- COMPLETED
- Registry status
- 300 participants
- Enrollment target
Study Summary
This is a pilot study to determine cancer detection rate of conventional/systematic versus targeted biopsy methods in diagnosis of potentially lethal prostate cancer. This is a diagnostic trial using each patient as his own control.
Interventions
- DEVICE Targeted biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2014-12-04 |
| Est. Completion | 2018-12-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02425228
The ClinicalTrials.gov registry entry for NCT02425228 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jonsson Comprehensive Cancer Center, which has 321 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Targeted biopsy is the first listed.
NCT02425228 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02425228 about?
NCT02425228 is a clinical study titled "Prospective Assessment of Image Registration for the Diagnosis of Prostate Cancer". This is a pilot study to determine cancer detection rate of conventional/systematic versus targeted biopsy methods in diagnosis of potentially lethal prostate cancer. This is a diagnostic trial using each patient as his own control.
What is the current status of trial NCT02425228?
This trial is currently completed. The enrollment target is 300 participants. The study started on 2014-12-04. Estimated completion is 2018-12-18.
What interventions are being tested in trial NCT02425228?
The interventions under investigation include: Targeted biopsy (DEVICE).
Who is sponsoring clinical trial NCT02425228?
This trial is sponsored by Jonsson Comprehensive Cancer Center, which has 321 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.